13D/13G Filings - MPM BIOVENTURES 2018 L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-02-12
4:06 pm
Sale
2023-12-31 13G Dyne Therapeutics, Inc.
DYN
MPM BIOVENTURES 2018 L.P. 3,451,303
4.300%
-1,519,596decrease
(-30.57%)
Filing
History
2023-02-09
4:04 pm
Purchase
2022-12-31 13G Dyne Therapeutics, Inc.
DYN
MPM BIOVENTURES 2018 L.P. 4,970,899
9.500%
19,596increase
(+0.40%)
Filing
History
2021-02-12
4:24 pm
Purchase
2020-12-31 13G Dyne Therapeutics, Inc.
DYN
MPM BIOVENTURES 2018 L.P. 4,951,303
10.900%
4,951,303increase
(New Position)
Filing
History